Papillary Tumor of the Pineal Region: Systematic Review and Analysis of Prognostic Factors

Página do item simplificado
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorYAMAKI, Vitor Nagai
dc.contributor.authorSOLLA, Davi Jorge Fontoura
dc.contributor.authorRIBEIRO, Renan Ribeiro
dc.contributor.authorSILVA, Saul Almeida da
dc.contributor.authorTEIXEIRA, Manoel Jacobsen
dc.contributor.authorFIGUEIREDO, Eberval Gadelha
dc.date.accessioned2019-11-06T18:48:38Z
dc.date.available2019-11-06T18:48:38Z
dc.date.issued2019
dc.description.abstractBACKGROUND Clinical outcomes and biological behavior of papillary tumors of the pineal region (PTPR) are still under investigation. The best therapeutic strategy has not been defined. OBJECTIVE To perform a comprehensive patient-level analysis of all PTPR cases and identify their clinical features, treatment options, and prognostic factors. METHODS A search of the medical databases for case series and reports on PTPRs from January 2003 to June 2017 was performed. Data addressing PTPR's clinical presentation, imaging, treatment, and histological features were. Variables associated with the primary outcome of 36-mo survival were identified through Cox regression models. RESULTS The initial search yielded 1164 studies, of which 71 were included (60 case reports and 11 case series), containing 177 patients (mean age 33.0 15.3 yr and 53.2% male). Intracranial hypertension and hydrocephalus prevailed as the clinical picture. Surgery was performed on 82.0% and gross total resection (GTR) was achieved on 71.4%. A total of 56.8% recurred after a median 29 mo (quartiles 10.5-45.5). The 36-mo survival rate was 83.5% (95% confidence interval [CI] 76.2-89.2%). Good functional outcomes (Glasgow Outcome Scale 4/5) were observed in 60.0%. The variables of interest were inconsistently reported and the multivariable analysis final sample was 133 patients. After adjustment for age, tumor size (each additional centimeter, hazard ratio [HR] 1.99, 95% CI 1.12-3.53, P = .019) and surgical treatment (HR 0.16, 95% CI 0.05-0.45, P = .001) were associated with 36-mo survival. CONCLUSION Tumor size and surgery are associated with improvement in 36-mo survival. We did not observe any significant benefits from GTR or adjuvant treatments.eng
dc.description.indexMEDLINEeng
dc.identifier.citationNEUROSURGERY, v.85, n.3, p.E420-E429, 2019
dc.identifier.doi10.1093/neuros/nyz062
dc.identifier.eissn1524-4040
dc.identifier.issn0148-396X
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/34051
dc.language.isoeng
dc.publisherOXFORD UNIV PRESS INCeng
dc.relation.ispartofNeurosurgery
dc.rightsrestrictedAccesseng
dc.rights.holderCopyright OXFORD UNIV PRESS INCeng
dc.subjectBrain neoplasmseng
dc.subjectPineal glandeng
dc.subjectPapillary tumor of the pineal regioneng
dc.subjectSystematic revieweng
dc.subjectMeta-analysiseng
dc.subject.otherglioneuronal tumoreng
dc.subject.otherfeatureseng
dc.subject.otherdiagnosiseng
dc.subject.otherradiosurgeryeng
dc.subject.otherradiotherapyeng
dc.subject.othermulticentereng
dc.subject.otherexpressioneng
dc.subject.otherentitieseng
dc.subject.othersurgeryeng
dc.subject.wosClinical Neurologyeng
dc.subject.wosSurgeryeng
dc.titlePapillary Tumor of the Pineal Region: Systematic Review and Analysis of Prognostic Factorseng
dc.typearticleeng
dc.type.categoryrevieweng
dc.type.versionpublishedVersioneng
dspace.entity.typePublication
hcfmusp.citation.scopus21
hcfmusp.contributor.author-fmusphcVITOR NAGAI YAMAKI
hcfmusp.contributor.author-fmusphcDAVI JORGE FONTOURA SOLLA
hcfmusp.contributor.author-fmusphcRENAN RIBEIRO E RIBEIRO
hcfmusp.contributor.author-fmusphcSAUL ALMEIDA DA SILVA
hcfmusp.contributor.author-fmusphcMANOEL JACOBSEN TEIXEIRA
hcfmusp.contributor.author-fmusphcEBERVAL GADELHA FIGUEIREDO
hcfmusp.description.beginpageE420
hcfmusp.description.endpageE429
hcfmusp.description.issue3
hcfmusp.description.volume85
hcfmusp.origemWOS
hcfmusp.origem.pubmed30989225
hcfmusp.origem.scopus2-s2.0-85071351381
hcfmusp.origem.wosWOS:000489702900021
hcfmusp.publisher.cityCARYeng
hcfmusp.publisher.countryUSAeng
hcfmusp.relation.referenceAbela L, 2013, CHILD NERV SYST, V29, P307, DOI 10.1007/s00381-012-1935-1eng
hcfmusp.relation.referenceAggarwal Sushil Kumar, 2016, Asian J Neurosurg, V11, P78, DOI 10.4103/1793-5482.172592eng
hcfmusp.relation.referenceAlkhotani A, 2014, BRAIN PATHOL, V24, P191, DOI 10.1111/bpa.12121eng
hcfmusp.relation.referenceBoco T, 2008, NEUROPATHOLOGY, V28, P87, DOI 10.1111/j.1440-1789.2007.00832.xeng
hcfmusp.relation.referenceBuffenoir K, 2008, CHILD NERV SYST, V24, P379, DOI 10.1007/s00381-007-0500-9eng
hcfmusp.relation.referenceCardenas R, 2010, NEUROL INDIA, V58, P471, DOI 10.4103/0028-3886.66051eng
hcfmusp.relation.referenceCerase A, 2009, J NEURO-ONCOL, V95, P433, DOI 10.1007/s11060-009-9931-3eng
hcfmusp.relation.referenceChang AH, 2008, AM J NEURORADIOL, V29, P187, DOI 10.3174/ajnr.A0784eng
hcfmusp.relation.referenceChatterjee D, 2015, NEUROL INDIA, V63, P567, DOI 10.4103/0028-3886.162055eng
hcfmusp.relation.referenceCimino PJ, 2015, NEUROSURGERY, V77, P621, DOI 10.1227/NEU.0000000000000877eng
hcfmusp.relation.referenceCoello AF, 2009, NEUROLOGY, V73, P486, DOI 10.1212/WNL.0b013e3181b16637eng
hcfmusp.relation.referenceCohan JN, 2011, J NEURO-ONCOL, V101, P301, DOI 10.1007/s11060-010-0242-5eng
hcfmusp.relation.referenceCohen AL, 2013, CASE REP ONCOL, V6, P434, DOI 10.1159/000354753eng
hcfmusp.relation.referenceCykowski MD, 2012, ULTRASTRUCT PATHOL, V36, P68, DOI 10.3109/01913123.2011.620222eng
hcfmusp.relation.referenceDagnew E, 2007, NEUROSURGERY, V60, P953, DOI 10.1227/01.NEU.0000255443.44365.77eng
hcfmusp.relation.referenceDeiana G, 2015, NEUROCHIRURGIE, V61, P113, DOI 10.1016/j.neuchi.2014.10.111eng
hcfmusp.relation.referenceDhillon J, 2010, CYTOPATHOLOGY, V21, P267, DOI 10.1111/j.1365-2303.2009.00696.xeng
hcfmusp.relation.referenceEdson MA, 2015, WORLD NEUROSURG, V84, P76, DOI 10.1016/j.wneu.2015.02.031eng
hcfmusp.relation.referenceEl Majdoub F, 2012, J NEURO-ONCOL, V109, P99, DOI 10.1007/s11060-012-0870-zeng
hcfmusp.relation.referenceEpari S, 2011, NEUROL INDIA, V59, P455, DOI 10.4103/0028-3886.82773eng
hcfmusp.relation.referenceErsahin Y, 2005, J NEUROSURG, V102, P137eng
hcfmusp.relation.referenceFauchon F, 2013, J NEURO-ONCOL, V112, P223, DOI 10.1007/s11060-013-1050-5eng
hcfmusp.relation.referenceFevre-Montange M, 2008, NEUROPATHOLOGY, V28, P660, DOI 10.1111/j.1440-1789.2008.00906.xeng
hcfmusp.relation.referenceFevre-Montange M, 2006, J NEUROPATH EXP NEUR, V65, P1004, DOI 10.1097/01.jnen.0000240462.80263.13eng
hcfmusp.relation.referenceGutenberg A, 2011, BRAIN PATHOL, V21, P672, DOI 10.1111/j.1750-3639.2011.00493.xeng
hcfmusp.relation.referenceHasselblatt M, 2006, NEUROPATH APPL NEURO, V32, P278, DOI 10.1111/j.1365-2990.2006.00723.xeng
hcfmusp.relation.referenceHeim S, 2016, BRAIN PATHOL, V26, P199, DOI 10.1111/bpa.12282eng
hcfmusp.relation.referenceHeim S, 2014, AM J SURG PATHOL, V38, P106, DOI 10.1097/PAS.0b013e31829e492deng
hcfmusp.relation.referenceHeim S, 2013, J NEURO-ONCOL, V115, P127, DOI 10.1007/s11060-013-1202-7eng
hcfmusp.relation.referenceHong BJ, 2011, CLIN NEUROL NEUROSUR, V113, P235, DOI 10.1016/j.clineuro.2010.10.010eng
hcfmusp.relation.referenceHua XM, 2015, EXP THER MED, V10, P1375, DOI 10.3892/etm.2015.2696eng
hcfmusp.relation.referenceHusain N, 2009, NEUROL INDIA, V57, P792, DOI 10.4103/0028-3886.59481eng
hcfmusp.relation.referenceIacoangeli M, 2017, ACTA NEUROCHIR, V159, P645, DOI 10.1007/s00701-017-3117-0eng
hcfmusp.relation.referenceInoue T, 2008, BRAIN TUMOR PATHOL, V25, P85, DOI 10.1007/s10014-008-0231-yeng
hcfmusp.relation.referenceIshida A, 2013, BRAIN TUMOR PATHOL, V30, P45, DOI 10.1007/s10014-012-0098-9eng
hcfmusp.relation.referenceJeruc J PM, 2008, CLIN NEUROPATHOL, V27, P192eng
hcfmusp.relation.referenceJimenez-Heffernan JA, 2016, DIAGN CYTOPATHOL, V44, P1098, DOI 10.1002/dc.23560eng
hcfmusp.relation.referenceJouvet A, 2003, AM J SURG PATHOL, V27, P505, DOI 10.1097/00000478-200304000-00011eng
hcfmusp.relation.referenceKaloostian PE, 2013, AM J CASE REP, V14, P164, DOI 10.12659/AJCR.883919eng
hcfmusp.relation.referenceKaloshi G, 2010, J NEURO-ONCOL, V100, P487, DOI 10.1007/s11060-010-0198-5eng
hcfmusp.relation.referenceKamamoto D, 2016, BRAIN TUMOR PATHOL, V33, P271, DOI 10.1007/s10014-016-0270-8eng
hcfmusp.relation.referenceKawahara I, 2007, NEUROL MED-CHIR, V47, P568, DOI 10.2176/nmc.47.568eng
hcfmusp.relation.referenceKern M, 2006, CLIN NEUROPATHOL, V25, P185eng
hcfmusp.relation.referenceKim YH, 2010, NEUROPATHOLOGY, V30, P654, DOI 10.1111/j.1440-1789.2010.01108.xeng
hcfmusp.relation.referenceKonovalov AN, 2003, SURG NEUROL, V59, P250, DOI 10.1016/S0090-3019(03)00080-6eng
hcfmusp.relation.referenceKoziarski A, 2014, NEUROL NEUROCHIR POL, V48, P356, DOI 10.1016/j.pjnns.2014.09.005eng
hcfmusp.relation.referenceKuchelmeister K, 2006, NEUROPATH APPL NEURO, V32, P203, DOI 10.1111/j.1365-2990.2006.00741.xeng
hcfmusp.relation.referenceLechapt-Zalcman E, 2011, NEUROPATH APPL NEURO, V37, P431, DOI 10.1111/j.1365-2990.2010.01133.xeng
hcfmusp.relation.referenceLi J, 2011, J NEUROSURG-PEDIATR, V7, P534, DOI 10.3171/2011.2.PEDS10434eng
hcfmusp.relation.referenceLouis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4eng
hcfmusp.relation.referenceMagalhaes J, 2013, BRAIN TUMOR PATHOL, V30, P93, DOI 10.1007/s10014-012-0103-3eng
hcfmusp.relation.referenceMatyja E, 2011, FOLIA NEUROPATHOL, V49, P181eng
hcfmusp.relation.referenceMbekeani Joyce N, 2015, Hematol Oncol Stem Cell Ther, V8, P140, DOI 10.1016/j.hemonc.2015.06.002eng
hcfmusp.relation.referenceMobley BC, 2015, HUM PATHOL, V46, P1232, DOI 10.1016/j.humpath.2015.04.014eng
hcfmusp.relation.referenceMontange MF, 2015, NEUROCHIRURGIE, V61, P138, DOI 10.1016/j.neuchi.2013.04.011eng
hcfmusp.relation.referenceMontange MF, 2012, AM J SURG PATHOL, V36, P916, DOI 10.1097/PAS.0b013e31824b7114eng
hcfmusp.relation.referenceMottolese C, 2015, NEUROCHIRURGIE, V61, P65, DOI 10.1016/j.neuchi.2014.01.005eng
hcfmusp.relation.referenceMottolese C, 2015, NEUROCHIRURGIE, V61, P176, DOI 10.1016/j.neuchi.2014.02.004eng
hcfmusp.relation.referenceMottolese C, 2015, NEUROCHIRURGIE, V61, P223, DOI 10.1016/j.neuchi.2014.02.006eng
hcfmusp.relation.referenceMurali R, 2010, PATHOLOGY, V42, P474, DOI 10.3109/00313025.2010.494292eng
hcfmusp.relation.referenceNakamura H, 2009, BRAIN TUMOR PATHOL, V26, P73, DOI 10.1007/s10014-009-0250-3eng
hcfmusp.relation.referenceNowicka E, 2016, FOLIA NEUROPATHOL, V54, P72, DOI 10.5114/fn.2016.58918eng
hcfmusp.relation.referencePatil Meena, 2016, Asian J Neurosurg, V11, P453eng
hcfmusp.relation.referencePoulgrain K, 2011, J CLIN NEUROSCI, V18, P1007, DOI 10.1016/j.jocn.2010.12.027eng
hcfmusp.relation.referenceRickard KA, 2011, ANN CLIN LAB SCI, V41, P174eng
hcfmusp.relation.referenceRiis P, 2013, STEREOT FUNCT NEUROS, V91, P186, DOI 10.1159/000344023eng
hcfmusp.relation.referenceRoncaroli F, 2007, BRAIN PATHOL, V17, P314, DOI 10.1111/j.1750-3639.2007.00081.xeng
hcfmusp.relation.referenceSantarius T, 2008, BRIT J NEUROSURG, V22, P116, DOI 10.1080/02688690701583794eng
hcfmusp.relation.referenceSantoro A, 2012, NEUROL SCI, V33, P931, DOI 10.1007/s10072-011-0860-5eng
hcfmusp.relation.referenceSato TS, 2009, PEDIATR RADIOL, V39, P188, DOI 10.1007/s00247-008-1060-1eng
hcfmusp.relation.referenceShakir H, 2015, SURG NEUROL INT, V6, P451eng
hcfmusp.relation.referenceSharma MC, 2009, CLIN NEUROPATHOL, V28, P295eng
hcfmusp.relation.referenceShibahara J, 2004, ACTA NEUROPATHOL, V108, P337, DOI 10.1007/s00401-004-0898-zeng
hcfmusp.relation.referenceShiramizu H, 2013, NEUROSURG REV, V36, P467, DOI 10.1007/s10143-013-0455-0eng
hcfmusp.relation.referenceSun IS, 2015, ACTA NEUROCHIR, V157, P215, DOI 10.1007/s00701-014-2308-1eng
hcfmusp.relation.referenceVaghela V, 2010, Neurol India, V58, P928, DOI 10.4103/0028-3886.73750eng
hcfmusp.relation.referenceVandergriff Clayton, 2012, Proc (Bayl Univ Med Cent), V25, P78eng
hcfmusp.relation.referenceVarikatt W, 2009, NEUROPATHOLOGY, V29, P641, DOI 10.1111/j.1440-1789.2009.01038.xeng
hcfmusp.relation.referenceVieira G, 2011, BRAIN TUMOR PATHOL, V28, P329, DOI 10.1007/s10014-011-0040-6eng
hcfmusp.relation.referenceWong YS, 2012, BRAIN PATHOL, V22, P255, DOI 10.1111/j.1750-3639.2012.00570.xeng
hcfmusp.relation.referenceYano H, 2009, BRAIN TUMOR PATHOL, V26, P83, DOI 10.1007/s10014-009-0246-zeng
hcfmusp.scopus.lastupdate2024-05-10
relation.isAuthorOfPublicationbf46b370-7618-4b0c-bc02-f4a22afd3c3e
relation.isAuthorOfPublication3abe2eb6-24de-4aac-8ebe-dfcc806ee8f1
relation.isAuthorOfPublication288b8b8e-f942-40a1-982f-26b06802ebef
relation.isAuthorOfPublicationcdd45cf0-04d0-4545-b45f-2d8482c7e0c7
relation.isAuthorOfPublicationb665cf91-624e-4b90-92bc-9df755eeeaaf
relation.isAuthorOfPublicationb4a34dbe-d274-4cdd-8485-5c8e561da3a4
relation.isAuthorOfPublication.latestForDiscoverybf46b370-7618-4b0c-bc02-f4a22afd3c3e
Arquivos
Coleções
Artigos e Materiais de Revistas Científicas - FM/MNE
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/24
Artigos e Materiais de Revistas Científicas - LIM/26